
Mohammad S. Rostami
Examiner (ID: 14480, Phone: (571)270-1980 , Office: P/2154 )
| Most Active Art Unit | 2154 |
| Art Unit(s) | 2169, 2156, 2154 |
| Total Applications | 706 |
| Issued Applications | 452 |
| Pending Applications | 73 |
| Abandoned Applications | 208 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7645550
[patent_doc_number] => 06472420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-29
[patent_title] => 'Method for treating a patient with neoplasia by treatment with a paclitaxel derivative'
[patent_app_type] => B2
[patent_app_number] => 10/038634
[patent_app_country] => US
[patent_app_date] => 2002-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 24
[patent_no_of_words] => 9524
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/472/06472420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038634
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038634 | Method for treating a patient with neoplasia by treatment with a paclitaxel derivative | Jan 2, 2002 | Issued |
Array
(
[id] => 1575155
[patent_doc_number] => 06468997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-10-22
[patent_title] => 'Desmethylolanzapine compositions and methods'
[patent_app_type] => B2
[patent_app_number] => 10/026303
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3162
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/468/06468997.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026303 | Desmethylolanzapine compositions and methods | Dec 18, 2001 | Issued |
Array
(
[id] => 5936724
[patent_doc_number] => 20020061910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method of treating or preventing chronic pain'
[patent_app_type] => new
[patent_app_number] => 10/020261
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9163
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020261 | Method of treating chronic pain | Dec 13, 2001 | Issued |
Array
(
[id] => 5935448
[patent_doc_number] => 20020061311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Methods and compositions for inducing oral tolerance in mammals'
[patent_app_type] => new
[patent_app_number] => 10/017076
[patent_app_country] => US
[patent_app_date] => 2001-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8064
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017076
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017076 | Methods and compositions for inducing oral tolerance in mammals | Dec 13, 2001 | Abandoned |
Array
(
[id] => 5846373
[patent_doc_number] => 20020133047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Isomeric nonanols and decanols, their preparation, phthalic esters obtained therefrom, and their use as plasticizers'
[patent_app_type] => new
[patent_app_number] => 10/020007
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3348
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20020133047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020007
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020007 | Isomeric nonanols and decanols, their preparation, phthalic esters obtained therefrom, and their use as plasticizers | Dec 12, 2001 | Abandoned |
Array
(
[id] => 1467458
[patent_doc_number] => 06458845
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-01
[patent_title] => 'Macrophage scavenger receptor antagonists'
[patent_app_type] => B1
[patent_app_number] => 10/018457
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4308
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/458/06458845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018457 | Macrophage scavenger receptor antagonists | Dec 11, 2001 | Issued |
| 90/006150 | EARLY SEASON NOT FROM CONCENTRATE ORANGE JUICE AND PROCESS OF MAKING | Nov 26, 2001 | Issued |
Array
(
[id] => 6651823
[patent_doc_number] => 20030105104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy'
[patent_app_type] => new
[patent_app_number] => 09/995010
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6374
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20030105104.pdf
[firstpage_image] =>[orig_patent_app_number] => 09995010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/995010 | Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy | Nov 26, 2001 | Abandoned |
Array
(
[id] => 6082745
[patent_doc_number] => 20020082304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-27
[patent_title] => 'Denaturants for sympathomimetic amine salts'
[patent_app_type] => new
[patent_app_number] => 09/996438
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7797
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20020082304.pdf
[firstpage_image] =>[orig_patent_app_number] => 09996438
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/996438 | Denaturants for sympathomimetic amine salts | Nov 19, 2001 | Abandoned |
Array
(
[id] => 6000633
[patent_doc_number] => 20020028802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-07
[patent_title] => 'Process for the isolation of galanthamine'
[patent_app_type] => new
[patent_app_number] => 09/986792
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 1840
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20020028802.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986792
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986792 | Process for the isolation of galanthamine | Nov 8, 2001 | Issued |
| 10/005515 | Novel compositions of eprosartan | Nov 7, 2001 | Abandoned |
Array
(
[id] => 961147
[patent_doc_number] => 06951860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-10-04
[patent_title] => 'Calcium channel blockers'
[patent_app_type] => utility
[patent_app_number] => 09/998623
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14537
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 394
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/951/06951860.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998623
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998623 | Calcium channel blockers | Oct 30, 2001 | Issued |
Array
(
[id] => 6706801
[patent_doc_number] => 20030153535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Primary N-hydroxylamines'
[patent_app_type] => new
[patent_app_number] => 10/038135
[patent_app_country] => US
[patent_app_date] => 2001-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18932
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10038135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/038135 | Primary N-hydroxylamines | Oct 19, 2001 | Abandoned |
Array
(
[id] => 1046892
[patent_doc_number] => 06864288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'Regulation of phospholipase D activity'
[patent_app_type] => utility
[patent_app_number] => 10/004155
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15292
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864288.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004155 | Regulation of phospholipase D activity | Oct 18, 2001 | Issued |
Array
(
[id] => 982394
[patent_doc_number] => 06927238
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-09
[patent_title] => 'Regulation of phospholipase D activity'
[patent_app_type] => utility
[patent_app_number] => 10/042043
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15287
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 542
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/927/06927238.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042043 | Regulation of phospholipase D activity | Oct 18, 2001 | Issued |
| 10/040046 | Plant fertilizer compositions containing phosphonate and phosphate salts and derivatives thereof | Oct 18, 2001 | Abandoned |
Array
(
[id] => 1399671
[patent_doc_number] => 06531511
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-11
[patent_title] => '2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission'
[patent_app_type] => B1
[patent_app_number] => 09/890061
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8724
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/531/06531511.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890061
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890061 | 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission | Oct 15, 2001 | Issued |
Array
(
[id] => 6783574
[patent_doc_number] => 20030065022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => 'Injectable composition'
[patent_app_type] => new
[patent_app_number] => 09/970558
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1228
[patent_no_of_claims] => 304
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20030065022.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970558
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970558 | Injectable composition | Oct 3, 2001 | Issued |
Array
(
[id] => 1316091
[patent_doc_number] => 06608050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-08-19
[patent_title] => 'Lyophilizate of lipid complex of water insoluble porphyrins'
[patent_app_type] => B2
[patent_app_number] => 09/970596
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4063
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/608/06608050.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970596
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970596 | Lyophilizate of lipid complex of water insoluble porphyrins | Oct 3, 2001 | Issued |
| 09/958121 | Use of arylalkanoylpyridazines | Oct 3, 2001 | Abandoned |